Dr Evan Mulligan Dr Susan Tudhope Dr Jill Hunter Sarah Elliott Dr Jonathan Wallis et al. | Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling | 2023 |
|
Dr Elaine Willmore Dr Aaron Ions Gardner Dr Susan Tudhope Belinda Murtani Jessica Caffry et al. | Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells | 2015 |
|
Dr Ashleigh Herriott Dr Susan Tudhope Gesa Junge Natalie Rodrigues Dr Miranda Patterson et al. | PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in Chronic Lymphocytic Leukaemia | 2015 |
|
Dr Asima Mukhopadhyay Michelle Dixon Dr Evan Mulligan James Murray Professor Nicola Curtin et al. | Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer | 2014 |
|
Professor Ruth Plummer Dr Evan Mulligan Professor Nicola Curtin Professor Alan Calvert
| A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation | 2013 |
|
Dr Susan Tudhope Dr Evan Mulligan Dr Jill Hunter Dr Helen Marr Professor barbara Durkacz et al. | P B S-1086, a "Pan-Rel" Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells | 2012 |
|
Dr sarah Johnson Clark Crawford Dr Evan Mulligan Dr Jonathan Wallis Dr Tryfonia Mainou-Fowler et al. | Mitoxantrone in combination with an inhibitor of DNA-dependent kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia | 2011 |
|
Dr Yvette Drew Dr Evan Mulligan Wan Vong Huw Thomas Suzanne Kyle et al. | Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2 | 2011 |
|
Huw Thomas Suzanne Kyle Rafal Zur Dr Evan Mulligan Professor Nicola Curtin et al. | 6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance | 2010 |
|
Dr Elaine Willmore Dr Evan Mulligan Dr Sarah Elliott Professor barbara Durkacz
| ATM Mutant Chronic Lymphocytic Leukaemia Cells are Chemosensitized by Inhibition of DNA Dependent Protein Kinase | 2010 |
|
Rachel Daniel Dr Agata Rozanska Dr Evan Mulligan Dr Yvette Drew Huw Thomas et al. | Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699 | 2010 |
|
Dr Evan Mulligan Dr Natalie Ferry Professor Angharad MR Gatehouse
| Characterisation of adult green lacewing (Chrysoperla carnea) digestive physiology: impact of a cysteine protease inhibito and a synthetic pyrethroid | 2010 |
|
Dr Evan Mulligan Arabella Baird Dr Jonathan Wallis Dr Stephany Veuger Professor barbara Durkacz et al. | Relationships Between Aberrant Activity of the NF-kappa B Subunits and Outcome In Chronic Lymphocytic Leukemia: The Dual Role of DNA Damage Sensor Enzymes | 2010 |
|
Dr Agata Rozanska Dr Evan Mulligan Huw Thomas Deborah Castelbuono Professor Deborah Tweddle et al. | [abstract] Central nervous system (CNS) penetration, poly-ADP ribose polymerase (PARP) inhibition and enhancement of temozolomide activity against childhood medulloblastoma by AG-014699 | 2009 |
|
Dr Evan Mulligan Tomasz Zaremba Dr Yvette Drew Professor Ruth Plummer Professor Nicola Curtin et al. | [abstract] Validated sensitive immunological determination of PARP-1 protein levels and activity in cultured cells and human lymphocytes | 2009 |
|
Dr Evan Mulligan Professor Nicola Curtin Professor Ruth Plummer
| Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines | 2009 |
|
Dr Agata Rozanska Huw Thomas Dr Evan Mulligan Dr Yvette Drew Deborah Castelbuono et al. | Inhibition of Poly (ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma | 2009 |
|
Dr Natalie Ferry Dr Evan Mulligan Professor Angharad MR Gatehouse
| Bitrophic and tritrophic effects of Bt Cry3A transgenic potato on beneficial, non-target, beetles | 2007 |
|
Dr Evan Mulligan Dr Natalie Ferry Dr Gordon Port Professor Angharad MR Gatehouse
| Comparing the impact of conventional pesticide and use of a transgenic pest-resistant crop on the beneficial carabid beetle Pterostichus melanarius | 2006 |
|
Dr Natalie Ferry Dr Evan Mulligan Dr Gordon Port Professor Angharad MR Gatehouse
| Prey-mediated effects of transgenic canola on a beneficial, non-target, carabid beetle | 2006 |
|
Dr Natalie Ferry Dr Evan Mulligan Dr Kaveh Emami Professor Angharad MR Gatehouse
| Impact of oilseed rape expressing the insecticidal serine protease inhibitor, mustard trypsin inhibitor-2 on the beneficial predator Pterostichus madidus | 2005 |
|
Dr Evan Mulligan
| Influence of Bt-transgenic pollen, Bt-toxin and protease inhibitor (SBTI) ingestion on development of the hypopharyngeal glands in honeybees | 2005 |
|
Dr Natalie Ferry Dr Martin Edwards Dr Evan Mulligan Dr Kaveh Emami Adelina Simeonova Petrova et al. | Engineering resistance to insect pests | 2004 |
|
Dr Martin Edwards Dr Natalie Ferry Dr Evan Mulligan Dr Kaveh Emami Adelina Simeonova Petrova et al. | The Role of Biotechnology in Crop Protection:Current Status and Future Perspectives | 2004 |
|
Dr Evan Mulligan Dr Natalie Ferry Dr Gordon Port Professor Angharad MR Gatehouse
| Impacts of transgenic crop technology upon the field slug Deroceras reticulatum (Muller) | 2003 |
|